Lately, it seems as though gluten is being blamed for a vast host of ailments – everything from irritable bowel syndrome (IBS) to attention-deficit disorder – with an ever increasing number of people seeking relief through a gluten-free diet. While this strict regimen is absolutely critical for people with a confirmed diagnosis of celiac disease, […]
Accelerating diagnosis, treatments, and a cure for celiac disease and non-celiac gluten sensitivity through research, education, and advocacy.
In the August 15, 2017 issue of the esteemed Journal of the American Medical Association, a spotlight was cast on celiac disease and non-celiac gluten sensitivity, with a comprehensive review of the current state of diagnostics, treatment, and prognosis. Celiac disease affects approximately 1% of the population worldwide. It is not yet exactly understood why […]
ImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease Symposium (ICDS) in Delhi, India for a potential blood test that could detect celiac disease with a single gluten challenge. This blood test could also […]
Save the date for the University of Chicago Celiac Disease Center’s Annual Celiac Education Day on Saturday, October 21, 2017. Celiac Disease Foundation (CDF) is proud to be a co-sponsor of this important event and host a Patient Advocacy Workshop during the program. The program begins at 10:00 AM with a Q & A panel […]
Senators Lindsey Graham (R-SC), Bill Cassidy (R-LA), Dean Heller (R-NV), and Ron Johnson (R-WI) recently introduced legislation known as Graham-Cassidy to repeal and replace the Affordable Care Act (ACA). The hope of these lawmakers is to hold yet another vote on repeal before October 1st, so a simple majority (51 votes) is all that is […]
On September 18, 2017, Celiac Disease Foundation (CDF) representatives attended a Food and Drug Administration (FDA) meeting in White Oak, MD on the ongoing implementation of a benefit-risk framework to inform drug and medical device review and approval processes. Under legislative mandate, the FDA is seeking to formally incorporate the patient experience and perspective into […]